Therapie eines Zenker'schen Divertikels

T. Benter, Bernd Dörken(Charité - Universitätsmedizin Berlin), Wolfgang Ludwig(Centre National de la Recherche Scientifique), Sarantos Papadopoulos(Humboldt-Universität zu Berlin), Albrecht Kretzschmar(Roche (Switzerland)), L Klühs(Humboldt-Universität zu Berlin), Gernot Reich(Palmetto Hematology Oncology)

Medizinische Klinik - Intensivmedizin und Notfallmedizin

January 1, 2002

10.1007/s00063-002-1124-1

Cited by 0

Related Papers

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

|Blood|2007|971

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

|The Lancet|1998|964

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

|Journal of Clinical Investigation|1997|765

Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

|European Journal of Cancer|2011|615

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

|Annals of Oncology|2009|534